Award

Delivery Order #SPE2DR26FQVT4

Short-Term Delivery Order for Brimonidine Eye Drops to Support Healthcare Needs

Buyer

Defense Logistics Agency

Award Amount

$67.06

Ceiling

$67.06

Awarded

February 12, 2026

Period of Performance

Feb 12, 2026 – Feb 13, 2026

Identifier

SPE2DR26FQVT4

NAICS

424210

This award is a short-term delivery order contract issued under a pre-existing Indefinite Delivery Vehicle (IDV) held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and medical supplies. The contract covers the procurement of Brimonidine 0.2% eye drops in a 5ml volume, indicating its use in addressing specific medical treatments requiring this ophthalmic solution. The award is significant for ensuring timely availability of essential medications for the agency's healthcare operations, supporting patient care and treatment efficacy. The scope of work involves the delivery of this precise pharmaceutical product to the designated location in Park Ridge, Illinois, within a narrow, defined timeframe. This contract builds on the larger, ongoing IDV agreement awarded to DMS Pharmaceutical Group that secures a broad range of pharmaceutical products for an extended period, fostering reliable supply continuity. The award process reflects a continuation of the longstanding partnership with DMS Pharmaceutical Group, aimed at meeting urgent or situational medical supply needs promptly. The performance period is notably brief, highlighting the contract's purpose for immediate fulfillment and rapid delivery.

Description

4570966433!BRIMONIDINE 0.2% EYE DROP 5ML

View original record